Multiple Sclerosis: Evaluation of Purine Nucleotide Metabolism in Central Nervous System in Association with Serum Levels of Selected Fat-Soluble Antioxidants

<table>Spearman rank correlations between CSF purine nucleotide degradation products and serum <i>γ</i>-tocopherol in patients with multiple sclerosis. <i>γ</i>T: <i>γ</i>-tocopherol, Ado: adenosine, Ino: inosine, Hyp: hypoxanthine, Xan: xanthine, UA: uric acid, Guo: guanosine, and Gua: guanine.</table>

Multiple Sclerosis International

fig3

Figure 3

Figure 3: Multiple Sclerosis: Evaluation of Purine Nucleotide Metabolism in Central Nervous System in Association with Serum Levels of Selected Fat-Soluble Antioxidants 

Figure 3 | Multiple Sclerosis: Evaluation of Purine Nucleotide Metabolism in Central Nervous System in Association with Serum Levels of Selected Fat-Soluble Antioxidants 